Published in Acta Med Okayama on January 01, 2013
Overheated and melted intracranial pressure transducer as cause of thermal brain injury during magnetic resonance imaging: case report. J Neurosurg (2012) 1.99
Mesenchymal stem cells that produce neurotrophic factors reduce ischemic damage in the rat middle cerebral artery occlusion model. Mol Ther (2005) 1.91
BDNF gene-modified mesenchymal stem cells promote functional recovery and reduce infarct size in the rat middle cerebral artery occlusion model. Mol Ther (2004) 1.87
A simple and useful coma scale for patients with neurologic emergencies: the Emergency Coma Scale. Am J Emerg Med (2010) 1.53
Protective effect of heme oxygenase-1 on hepatic ischemia-reperfusion injury through inhibition of platelet adhesion to the sinusoids. J Gastroenterol Hepatol (2013) 1.45
Enhanced brain angiogenesis in chronic cerebral hypoperfusion after administration of plasmid human vascular endothelial growth factor in combination with indirect vasoreconstructive surgery. J Neurosurg (2005) 1.44
Assessment of the difference in posterior circulation involvement between pediatric and adult patients with moyamoya disease. J Neurosurg (2013) 1.42
Quantitative assessment of tumour extraction from dermoscopy images and evaluation of computer-based extraction methods for an automatic melanoma diagnostic system. Melanoma Res (2006) 1.42
Intoxication with over-the-counter antitussive medication containing dihydrocodeine and chlorpheniramine causes generalized convulsion and mixed acidosis. Intern Med (2008) 1.41
Exercise exerts neuroprotective effects on Parkinson's disease model of rats. Brain Res (2009) 1.33
Angiogenesis and invasion in glioma. Brain Tumor Pathol (2011) 1.31
Neuroprotective effects of vascular endothelial growth factor (VEGF) upon dopaminergic neurons in a rat model of Parkinson's disease. Eur J Neurosci (2004) 1.30
Anti-high mobility group box-1 monoclonal antibody protects the blood-brain barrier from ischemia-induced disruption in rats. Stroke (2011) 1.26
The NH2 terminus of influenza virus hemagglutinin-2 subunit peptides enhances the antitumor potency of polyarginine-mediated p53 protein transduction. J Biol Chem (2004) 1.19
Intravenous administration of mesenchymal stem cells exerts therapeutic effects on parkinsonian model of rats: focusing on neuroprotective effects of stromal cell-derived factor-1alpha. BMC Neurosci (2010) 1.11
Intravenous route of cell delivery for treatment of neurological disorders: a meta-analysis of preclinical results. Stem Cells Dev (2010) 1.09
Anti-high mobility group box-1 antibody therapy for traumatic brain injury. Ann Neurol (2012) 1.08
In vivo animal stroke models: a rationale for rodent and non-human primate models. Transl Stroke Res (2013) 1.07
Intravenous grafts of amniotic fluid-derived stem cells induce endogenous cell proliferation and attenuate behavioral deficits in ischemic stroke rats. PLoS One (2012) 1.05
Isolation and transplantation of dopaminergic neurons generated from mouse embryonic stem cells. Neurosci Lett (2004) 1.04
Embryonic neural stem cells transplanted in middle cerebral artery occlusion model of rats demonstrated potent therapeutic effects, compared to adult neural stem cells. Brain Res (2008) 1.04
The relationship between peritumoral brain edema and the expression of vascular endothelial growth factor and its receptors in intracranial meningiomas. J Neurooncol (2004) 1.03
An improved Internet-based melanoma screening system with dermatologist-like tumor area extraction algorithm. Comput Med Imaging Graph (2008) 1.01
Potent synergy of dual antitumor peptides for growth suppression of human glioblastoma cell lines. Mol Cancer Ther (2008) 0.99
Large supratentorial ectopic ependymoma with massive calcification and cyst formation--case report. Neurol Med Chir (Tokyo) (2004) 0.99
Neuroprotective effects of edaravone-administration on 6-OHDA-treated dopaminergic neurons. BMC Neurosci (2008) 0.98
Detection of seizure-associated high-frequency oscillations above 500Hz. Epilepsy Res (2009) 0.98
Remodeling of connexin 43 in the diabetic rat heart. Mol Cell Biochem (2006) 0.97
Nationwide investigation of the current status of therapeutic neuroendoscopy for ventricular and paraventricular tumors in Japan. J Neurosurg (2011) 0.93
Spinal cord stimulation for the treatment of abnormal posture and gait disorder in patients with Parkinson's disease. Neurol Med Chir (Tokyo) (2012) 0.93
An algorithm for estimating potential deposition of corn pollen for environmental assessment. Environ Biosafety Res (2005) 0.93
The potential role of vascular endothelial growth factor in the central nervous system. Rev Neurosci (2004) 0.93
Striatal stimulation nurtures endogenous neurogenesis and angiogenesis in chronic-phase ischemic stroke rats. Cell Transplant (2010) 0.92
[Assessment of the signal intensity distribution pattern within the unruptured cerebral aneurysms using color-coded 3D MR angiography]. No Shinkei Geka (2005) 0.92
Cilengitide treatment for malignant glioma: current status and future direction. Neurol Med Chir (Tokyo) (2012) 0.92
Control of postprandial hyperglycaemia by galactosyl maltobionolactone and its novel anti-amylase effect in mice. Life Sci (2002) 0.92
Ultrasound activation of TiO2 in melanoma tumors. J Control Release (2010) 0.92
Glioblastoma with metastasis to the spleen--case report. Neurol Med Chir (Tokyo) (2003) 0.91
Effects of deferoxamine-activated hypoxia-inducible factor-1 on the brainstem after subarachnoid hemorrhage in rats. Neurosurgery (2008) 0.91
The differences between high and low-dose administration of VEGF to dopaminergic neurons of in vitro and in vivo Parkinson's disease model. Brain Res (2005) 0.90
Inhibition of excitatory neuronal cell death by cell-permeable calcineurin autoinhibitory peptide. J Neurochem (2003) 0.90
Multiple intracranial hemorrhages after cervical spinal surgery. Neurol Med Chir (Tokyo) (2012) 0.90
Neurorescue effects of VEGF on a rat model of Parkinson's disease. Brain Res (2005) 0.89
Posterior decompression of far-out foraminal stenosis caused by a lumbosacral transitional vertebra--case report. Neurol Med Chir (Tokyo) (2011) 0.89
Role of VEGF and matrix metalloproteinase-9 in peritumoral brain edema associated with supratentorial benign meningiomas. Neuropathology (2012) 0.89
Influence of perianeurysmal environment on the deformation and bleb formation of the unruptured cerebral aneurysm: assessment with fusion imaging of 3D MR cisternography and 3D MR angiography. AJNR Am J Neuroradiol (2005) 0.89
Neuroprotective and restorative effects of intrastriatal grafting of encapsulated GDNF-producing cells in a rat model of Parkinson's disease. J Neurosci Res (2002) 0.88
Antivasospastic and antiinflammatory effects of caspase inhibitor in experimental subarachnoid hemorrhage. J Neurosurg (2007) 0.88
Intracerebral transplantation of genetically engineered cells for Parkinson's disease: toward clinical application. Cell Transplant (2007) 0.88
Fusion imaging of three-dimensional magnetic resonance cisternograms and angiograms for the assessment of microvascular decompression in patients with hemifacial spasms. J Neurosurg (2007) 0.88
[Surgical and endovascular treatment for superior cerebellar artery aneurysms: report of two cases]. No Shinkei Geka (2013) 0.87
Neuroprotective effects of liraglutide for stroke model of rats. Int J Mol Sci (2013) 0.87
Pseudoxanthoma elasticum with carotid rete mirabile. Clin Neurol Neurosurg (2004) 0.87
Posterior reversible encephalopathy syndrome. J Clin Neurosci (2011) 0.87
Novel animal glioma models that separately exhibit two different invasive and angiogenic phenotypes of human glioblastomas. World Neurosurg (2011) 0.87
Identification of glioma-specific RFX4-E and -F isoforms and humoral immune response in patients. Cancer Sci (2005) 0.86
Proteomics-based analysis of invasion-related proteins in malignant gliomas. Neuropathology (2012) 0.86
Newborn with transverse facial cleft associated with polyhydramnios. J Perinatol (2002) 0.86
Continuous intraventricular infusion of erythropoietin exerts neuroprotective/rescue effects upon Parkinson's disease model of rats with enhanced neurogenesis. Brain Res (2008) 0.85
Early transplantation of an encapsulated glial cell line-derived neurotrophic factor-producing cell demonstrating strong neuroprotective effects in a rat model of Parkinson disease. J Neurosurg (2005) 0.85
Epidemiology of dural arteriovenous fistula in Japan: Analysis of Japanese Registry of Neuroendovascular Therapy (JR-NET2). Neurol Med Chir (Tokyo) (2013) 0.85
Rebleeding from a vertebral artery dissecting aneurysm after endovascular internal trapping: adverse effect of intrathecal urokinase injection or incomplete occlusion?-case report-. Neurol Med Chir (Tokyo) (2009) 0.85
Alterations of connexin 43 in the diabetic rat heart. Adv Cardiol (2006) 0.85
Systemic neurotransplantation--a problem-oriented systematic review. Rev Neurosci (2009) 0.85
Three-phase general border detection method for dermoscopy images using non-uniform illumination correction. Skin Res Technol (2011) 0.84
Fine structure of myotendinous junction between the anterior belly of the digastric muscle and intermediate tendon in adults rats. Micron (2011) 0.84
The neuroprotective and neurorescue effects of carbamylated erythropoietin Fc fusion protein (CEPO-Fc) in a rat model of Parkinson's disease. Brain Res (2013) 0.84
Toxicity of semaphorin3A for dopaminergic neurons. Neurosci Lett (2005) 0.84
Comparison of the therapeutic potential of adult and embryonic neural precursor cells in a rat model of Parkinson disease. J Neurosurg (2008) 0.84
Bimodal anti-glioma mechanisms of cilengitide demonstrated by novel invasive glioma models. Neuropathology (2012) 0.84
Glial cell line-derived neurotrophic factor (GDNF) therapy for Parkinson's disease. Acta Med Okayama (2007) 0.84
Reduction of infarct volume and apoptosis by grafting of encapsulated basic fibroblast growth factor-secreting cells in a model of middle cerebral artery occlusion in rats. J Neurosurg (2003) 0.84
"Double-stick tape" technique for transposition of an offending vessel in microvascular decompression: technical case report. Neurosurgery (2011) 0.84
A proposal for standardized analysis of the results of microvascular decompression for trigeminal neuralgia and hemifacial spasm. Acta Neurochir (Wien) (2012) 0.83
Conformational significance of EH21A1-A4, phenolic derivatives of geldanamycin, for Hsp90 inhibitory activity. Bioorg Med Chem Lett (2008) 0.83
[Training in neurovascular intervention]. No Shinkei Geka (2002) 0.83
Primary germinoma in the medulla oblongata - case report - . Neurol Med Chir (Tokyo) (2011) 0.83